Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer

This study aimed to examine the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and other clinicopathological features in HER2+ MBC patients who received first-line anti-HER2 therapy. A total of 129 patients were assigned to NLR-low and NLR-high groups based on a cutoff value of 3.0 at...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Bin, Liu, Xiaoran, Li, Huiping, Song, Guohong, Di, Lijun, Jiang, Hanfang, Yan, Ying, Zhang, Ruyan, Ran, Ran, Zhang, Jiayang, Liu, Yaxin, Wang, Huan, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498194/
https://www.ncbi.nlm.nih.gov/pubmed/36135052
http://dx.doi.org/10.3390/curroncol29090483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498194/
https://www.ncbi.nlm.nih.gov/pubmed/36135052
http://dx.doi.org/10.3390/curroncol29090483

Ejemplares similares